Edition:
United States

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

12.22USD
9 Dec 2016
Change (% chg)

$0.29 (+2.43%)
Prev Close
$11.93
Open
$12.00
Day's High
$12.50
Day's Low
$11.94
Volume
70,902
Avg. Vol
95,806
52-wk High
$27.08
52-wk Low
$9.40

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Roger Newton

64 Executive Chairman of the Board, Chief Scientific Officer

Timothy Mayleben

55 2012 President, Chief Executive Officer, Director

Narendra Lalwani

62 2014 Chief Operating Officer, Executive Vice President - Research & Development

Mary McGowan

2015 Chief Medical Officer

Scott Braunstein

2015 Director